Current Editions
Front Row with BioCentury: Wake up to China’s first-in-class innovation
Introducing BioCentury’s new subscriber-only series on critical topics in biopharma
Product Development
Politics, Policy & Law
Republicans calling for firings over FDA approval of generic abortion pill
Sen. Hawley says he has ‘lost confidence’ in agency leaders, 13 GOP reps call for firing CDER Director Tidmarsh
Management Tracks
Former CBER Director Marks joins Lilly
He takes the role of SVP for molecule discovery and head of infectious diseases at the pharma
David Baltimore’s enduring legacy: Remembering ‘a giant of science’
A month after his passing, a reflection on how the Nobel-winning molecular biologist helped shape the culture and institutions of today’s biotech era
BioCentury ISSN 1097-7201